Akut mieloid leukémia (AML): vizsgálatok itt: Egyesült Államok
334 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Where
- Atlanta, Aurora, Cincinnati, Dallas, Fort Worth, Kansas City, Memphis, New York, Philadelphia, San Diego
- Életkor
- 1 év to 30 év
- People
- 24
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06177067 - 2/3. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
- Where
- Atlanta, Duarte, Houston, St Louis, Tampa, The Bronx
- Életkor
- 18 év and over
- People
- 660 worldwide
- Run by
- AbbVie
See details and how to joinNCT07581002 · EU 2025-523724-47-00 - No phaseNot yet taking people in Egyesült ÁllamokPrevention of Oral Mucositis in Adults in With Hematologic Malignancy
- Where
- Milwaukee, Oak Lawn, Park Ridge
- Életkor
- 18 év and over
- People
- 206
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07809984 - No phaseCsak meghívásosBiology Studies of Hematologic Cancers
- Where
- Bethesda
- Életkor
- 1 év to 120 év
- People
- 550
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00923442 - 1. fázisTaking peopleCER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
- Where
- Denver, Houston, Nashville, Sacramento, Seattle
- Életkor
- 18 év to 85 év
- People
- 18
- Run by
- CERo Therapeutics Holdings, Inc.
See details and how to joinNCT06834282 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Chapel Hill, Duarte, Farmington, Goodyear, Greenville, Houston, Indianapolis, Morristown, Providence, Shreveport, Tampa
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 2. fázisTaking peopleGraft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Where
- Pittsburgh, Seattle, Tampa
- Életkor
- 1 év to 60 év
- People
- 120
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT03970096 - No phaseTaking peopleBrain MRF in Children, Adolescents and Young Adults With Acute Leukemia
- Where
- Cleveland
- Életkor
- Up to 30 év
- People
- 20
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06421155 - 1. fázisTaking peopleEganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
- Where
- Aurora, Boston, Cleveland, Columbus, Duarte, Houston, New York, St Louis, Tampa
- Életkor
- 18 év and over
- People
- 105 worldwide
- Run by
- Stelexis BioSciences
See details and how to joinNCT06533761 · EU 2024-518071-58-00 - 1. fázisTaking peopleOlutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
- Where
- Cleveland, Duarte
- Életkor
- 18 év and over
- People
- 15
- Run by
- City of Hope Medical Center
See details and how to joinNCT06543381 - 2. fázisTaking peopleInduction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
- Where
- Portland
- Életkor
- 18 év to 65 év
- People
- 102
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07228273 - 1. fázisTaking peopleCD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML
- Where
- Aurora
- Életkor
- 18 év and over
- People
- 23
- Run by
- University of Colorado, Denver
See details and how to joinNCT07347418 - 1/2. fázisTaking peopleA Study of Revumenib and Mezigdomide in People With Leukemia
- Where
- Basking Ridge, Chapel Hill, Commack, Duarte, Harrison, Houston, Middletown, Montvale, New York, Rockville Centre
- Életkor
- 12 év and over
- People
- 52
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07356154 - 1. fázisTaking peopleRevumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
- Where
- Duarte
- Életkor
- 2 év and over
- People
- 27
- Run by
- City of Hope Medical Center
See details and how to joinNCT06575296 - No phaseTaking peopleRandomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
- Where
- Seattle
- Életkor
- 18 év and over
- People
- 50
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07094750 - No phaseTaking peopleComprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
- Where
- Bethesda
- Életkor
- 1 nap to 120 év
- People
- 1100
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05350748 - 1. fázisTaking peoplePhase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
- Where
- Buffalo, Chapel Hill, Columbus, Duarte, Houston, Nashville, New York, Philadelphia, Tampa
- Életkor
- 18 év and over
- People
- 69 worldwide
- Run by
- Auron Therapeutics, Inc.
See details and how to joinNCT06846606 · EU 2025-521394-13-00 - No phaseTaking peopleStudy of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
- Where
- Bethesda
- Életkor
- 1 hónap to 120 év
- People
- 510
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07019155 - 1. fázisNot yet taking people in Egyesült ÁllamokAxatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML
- Where
- Atlanta
- Életkor
- 18 év and over
- People
- 32
- Run by
- Northside Hospital, Inc.
See details and how to joinNCT07511062 - No phaseCsak meghívásosForecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)
- Where
- Brisbane, San Francisco, St Louis
- Életkor
- 18 év and over
- People
- 400
- Run by
- CareDx
See details and how to joinNCT07607327 - 1. fázisTaking peopleDanvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
- Where
- Houston, The Bronx
- Életkor
- 18 év and over
- People
- 38
- Run by
- Montefiore Medical Center
See details and how to joinNCT05986240 - 1. fázisTaking peopleNiclosamide in Pediatric Patients With Relapsed and Refractory AML
- Where
- Palo Alto
- Életkor
- 2 év to 30 év
- People
- 16
- Run by
- Stanford University
See details and how to joinNCT05188170 - 2. fázisTaking peopleRuxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
- Where
- Duarte
- Életkor
- 2 év to 22 év
- People
- 40
- Run by
- City of Hope Medical Center
See details and how to joinNCT06128070 - 1. fázisTaking peoplePET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia
- Where
- Houston
- Életkor
- 18 év and over
- People
- 77
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02390635 - 2. fázisNot yet taking people in Egyesült ÁllamokCD34+ Transplants for Myeloid Malignancies
- Where
- Miami
- Életkor
- 18 év to 70 év
- People
- 50
- Run by
- Guenther Koehne
See details and how to joinNCT05565105